Last reviewed · How we verify
Insulin Detemir, Insulin Insulatard
Insulin Detemir, Insulin Insulatard is a Small molecule drug developed by Rigshospitalet, Denmark. It is currently FDA-approved.
At a glance
| Generic name | Insulin Detemir, Insulin Insulatard |
|---|---|
| Sponsor | Rigshospitalet, Denmark |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Impact on Birth Weight of Two Therapeutic Strategies (Insulin Therapy From the Beginning of Pregnancy vs. Insulin Therapy Initiated According to Fetal Growth Evaluated by Ultrasonography Measurements) in Pregnant Women With Monogenic Diabetes (NA)
- DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes (PHASE4)
- Effect of Insulin Detemir on Blood Glucose Control in Subjects With Type 2 Diabetes (PHASE3)
- The Effect of Exercise on Blood Glucose Levels in Patients With Type 1 Diabetes: A Comparison of 3 Long-acting Insulins (PHASE4)
- Comparison of Insulin Detemir Versus Insulin NPH on Weight Change in Overweight and Obese With Type 2 Diabetes (PHASE3)
- The Effect of Insulin Detemir on Blood Glucose Control in Taiwanese Patients With Type 2 Diabetes Failing on OAD (PHASE4)
- DETERMINE: Detemir vs NPH (PHASE2)
- Comparison of Insulin Detemir and NPH Insulin Given Once Daily in Ageing Subjects With Type 2 Diabetes (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Insulin Detemir, Insulin Insulatard CI brief — competitive landscape report
- Insulin Detemir, Insulin Insulatard updates RSS · CI watch RSS
- Rigshospitalet, Denmark portfolio CI
Frequently asked questions about Insulin Detemir, Insulin Insulatard
What is Insulin Detemir, Insulin Insulatard?
Insulin Detemir, Insulin Insulatard is a Small molecule drug developed by Rigshospitalet, Denmark.
Who makes Insulin Detemir, Insulin Insulatard?
Insulin Detemir, Insulin Insulatard is developed and marketed by Rigshospitalet, Denmark (see full Rigshospitalet, Denmark pipeline at /company/rigshospitalet-denmark).
What development phase is Insulin Detemir, Insulin Insulatard in?
Insulin Detemir, Insulin Insulatard is FDA-approved (marketed).